Biochemically, T1D is associated with reductions in the anabolic agents of bone formation including IGF-1 and transforming growth factor beta 1 (TGFβ1), which initiate a potent stimulatory effect on the synthesis of bone-specific proteins and osteoblastic proliferation potential (92). This evidence concerns the gene TGFB1 and type 1 diabetes mellitus.